Literature DB >> 16098592

Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.

Martine T Barel1, Gerco C Hassink, Sjaak van Voorden, Emmanuel J H J Wiertz.   

Abstract

Surface MHC class I molecules serve important immune functions as ligands for both T and NK cell receptors for the elimination of infected and malignant cells. In order to reach the cell surface, MHC class I molecules have to fold properly and form trimers consisting of a heavy chain (HC), a beta2-microglobulin light chain and an 8-10-mer peptide. A panel of ER chaperones facilitates the folding and assembly process. Incorrectly assembled or folded MHC class I HCs are detected by the ER quality-control system and transported to the cytosol for degradation by proteasomes. In human cytomegalovirus-infected cells, two viral proteins are synthesized, US2 and US11, which target MHC class I HCs for proteasomal degradation. It is unknown at which stage of MHC class I folding and complex formation US2 and US11 come into play. In addition, it is unclear if the disposal takes place via the same pathway through which proteins are removed that fail to pass ER quality control. In this study, we show with a beta2m-deficient cell line that US2 and US11 both target unassembled HCs for degradation. This suggests that US2 and US11 both act at an early stage of MHC class I complex formation. In addition, our data indicate that US11-mediated degradation involves mechanisms that are similar to those normally used to remove terminally misfolded HCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098592     DOI: 10.1016/j.molimm.2005.07.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

Review 1.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

Review 2.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

Review 3.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

4.  Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.

Authors:  Anabel S de la Garza-Rodea; Marieke C Verweij; Hester Boersma; Ietje van der Velde-van Dijke; Antoine A F de Vries; Rob C Hoeben; Dirk W van Bekkum; Emmanuel J H J Wiertz; Shoshan Knaän-Shanzer
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

5.  Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation.

Authors:  Nandini Sen; Adrish Sen; Erich R Mackow
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation.

Authors:  Seong-Ok Lee; Kwangmin Cho; Sunglim Cho; Ilkwon Kim; Changhoon Oh; Kwangseog Ahn
Journal:  EMBO J       Date:  2009-11-26       Impact factor: 11.598

7.  The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms.

Authors:  Laura L Winkler; Robert F Kalejta
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

8.  Phase-dependent immune evasion of herpesviruses.

Authors:  Tal Vider-Shalit; Vered Fishbain; Shai Raffaeli; Yoram Louzoun
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

9.  Feeling manipulated: cytomegalovirus immune manipulation.

Authors:  Mindy Miller-Kittrell; Tim E Sparer
Journal:  Virol J       Date:  2009-01-09       Impact factor: 4.099

10.  Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.

Authors:  Colin J Powers; Klaus Früh
Journal:  PLoS Pathog       Date:  2008-10-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.